Skip to main content
Erschienen in: Diabetologia 3/2015

01.03.2015 | Article

MafA is critical for maintenance of the mature beta cell phenotype in mice

verfasst von: Wataru Nishimura, Satoru Takahashi, Kazuki Yasuda

Erschienen in: Diabetologia | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

The plasticity of adult somatic cells allows for their dedifferentiation or conversion to different cell types, although the relevance of this to disease remains elusive. Perturbation of beta cell identity leading to dedifferentiation may be implicated in the compromised functions of beta cells in diabetes, which is a current topic of islet research. This study aims to investigate whether or not v-Maf musculoaponeurotic fibrosarcoma oncogene family, protein A (MafA), a mature beta cell marker, is involved in maintaining mature beta cell phenotypes.

Methods

The fate and gene expression of beta cells were analysed in Mafa knockout (KO) mice and mouse models of diabetes in which the expression of MafA was reduced in the majority of beta cells.

Results

Loss of MafA reduced the beta to alpha cell ratio in pancreatic islets without elevating blood glucose to diabetic levels. Lineage tracing analyses showed reduced/lost expression of insulin in most beta cells, with a minority of the former beta cells converted to glucagon-expressing cells in Mafa KO mice. The upregulation of genes that are normally repressed in mature beta cells or transcription factors that are transiently expressed in endocrine progenitors was identified in Mafa KO islets as a hallmark of dedifferentiation. The compromised beta cells in db/db and multiple low-dose streptozotocin mice underwent similar dedifferentiation with expression of Mafb, which is expressed in immature beta cells.

Conclusions/interpretation

The maturation factor MafA is critical for the homeostasis of mature beta cells and regulates cell plasticity. The loss of MafA in beta cells leads to a deeper loss of cell identity, which is implicated in diabetes pathology.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663–676PubMedCrossRef Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663–676PubMedCrossRef
2.
Zurück zum Zitat Jopling C, Boue S, Izpisua Belmonte JC (2011) Dedifferentiation, transdifferentiation and reprogramming: three routes to regeneration. Nat Rev Mol Cell Biol 12:79–89PubMedCrossRef Jopling C, Boue S, Izpisua Belmonte JC (2011) Dedifferentiation, transdifferentiation and reprogramming: three routes to regeneration. Nat Rev Mol Cell Biol 12:79–89PubMedCrossRef
3.
Zurück zum Zitat Thorel F, Népote V, Avril I et al (2010) Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss. Nature 464:1149–1154PubMedCentralPubMedCrossRef Thorel F, Népote V, Avril I et al (2010) Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss. Nature 464:1149–1154PubMedCentralPubMedCrossRef
4.
Zurück zum Zitat Dhawan S, Georgia S, Tschen SI, Fan G, Bhushan A (2011) Pancreatic beta cell identity is maintained by DNA methylation-mediated repression of Arx. Dev Cell 20:419–429PubMedCentralPubMedCrossRef Dhawan S, Georgia S, Tschen SI, Fan G, Bhushan A (2011) Pancreatic beta cell identity is maintained by DNA methylation-mediated repression of Arx. Dev Cell 20:419–429PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Papizan JB, Singer RA, Tschen SI et al (2011) Nkx2.2 repressor complex regulates islet β-cell specification and prevents β-to-α-cell reprogramming. Genes Dev 25:2291–2305PubMedCentralPubMedCrossRef Papizan JB, Singer RA, Tschen SI et al (2011) Nkx2.2 repressor complex regulates islet β-cell specification and prevents β-to-α-cell reprogramming. Genes Dev 25:2291–2305PubMedCentralPubMedCrossRef
6.
Zurück zum Zitat Elghazi L, Weiss AJ, Barker DJ et al (2009) Regulation of pancreas plasticity and malignant transformation by Akt signaling. Gastroenterology 136:1091–1103PubMedCentralPubMedCrossRef Elghazi L, Weiss AJ, Barker DJ et al (2009) Regulation of pancreas plasticity and malignant transformation by Akt signaling. Gastroenterology 136:1091–1103PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Landsman L, Parent A, Hebrok M (2011) Elevated hedgehog/Gli signaling causes beta-cell dedifferentiation in mice. Proc Natl Acad Sci U S A 108:17010–17015PubMedCentralPubMedCrossRef Landsman L, Parent A, Hebrok M (2011) Elevated hedgehog/Gli signaling causes beta-cell dedifferentiation in mice. Proc Natl Acad Sci U S A 108:17010–17015PubMedCentralPubMedCrossRef
8.
Zurück zum Zitat Talchai C, Xuan S, Lin HV, Sussel L, Accili D (2012) Pancreatic beta cell dedifferentiation as a mechanism of diabetic beta cell failure. Cell 150:1223–1234PubMedCentralPubMedCrossRef Talchai C, Xuan S, Lin HV, Sussel L, Accili D (2012) Pancreatic beta cell dedifferentiation as a mechanism of diabetic beta cell failure. Cell 150:1223–1234PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Collombat P, Xu X, Ravassard P et al (2009) The ectopic expression of Pax4 in the mouse pancreas converts progenitor cells into alpha and subsequently beta cells. Cell 138:449–462PubMedCentralPubMedCrossRef Collombat P, Xu X, Ravassard P et al (2009) The ectopic expression of Pax4 in the mouse pancreas converts progenitor cells into alpha and subsequently beta cells. Cell 138:449–462PubMedCentralPubMedCrossRef
10.
Zurück zum Zitat Collombat P, Hecksher-Sørensen J, Krull J et al (2007) Embryonic endocrine pancreas and mature beta cells acquire alpha and PP cell phenotypes upon Arx misexpression. J Clin Invest 117:961–970PubMedCentralPubMedCrossRef Collombat P, Hecksher-Sørensen J, Krull J et al (2007) Embryonic endocrine pancreas and mature beta cells acquire alpha and PP cell phenotypes upon Arx misexpression. J Clin Invest 117:961–970PubMedCentralPubMedCrossRef
11.
Zurück zum Zitat Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA (2008) In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 455:627–632PubMedCrossRef Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA (2008) In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 455:627–632PubMedCrossRef
12.
Zurück zum Zitat Jonas JC, Sharma A, Hasenkamp W et al (1999) Chronic hyperglycemia triggers loss of pancreatic beta cell differentiation in an animal model of diabetes. J Biol Chem 274:14112–14121PubMedCrossRef Jonas JC, Sharma A, Hasenkamp W et al (1999) Chronic hyperglycemia triggers loss of pancreatic beta cell differentiation in an animal model of diabetes. J Biol Chem 274:14112–14121PubMedCrossRef
13.
Zurück zum Zitat Wang Z, York NW, Nichols CG, Remedi MS (2014) Pancreatic β cell dedifferentiation in diabetes and redifferentiation following insulin therapy. Cell Metab 19:872–882PubMedCrossRef Wang Z, York NW, Nichols CG, Remedi MS (2014) Pancreatic β cell dedifferentiation in diabetes and redifferentiation following insulin therapy. Cell Metab 19:872–882PubMedCrossRef
14.
15.
16.
Zurück zum Zitat Puri S, Akiyama H, Hebrok M (2013) VHL-mediated disruption of Sox9 activity compromises β-cell identity and results in diabetes mellitus. Genes Dev 27:2563–2575PubMedCentralPubMedCrossRef Puri S, Akiyama H, Hebrok M (2013) VHL-mediated disruption of Sox9 activity compromises β-cell identity and results in diabetes mellitus. Genes Dev 27:2563–2575PubMedCentralPubMedCrossRef
17.
Zurück zum Zitat Tata PR, Mou H, Pardo-Saganta A et al (2013) Dedifferentiation of committed epithelial cells into stem cells in vivo. Nature 503:218–223PubMedCentralPubMed Tata PR, Mou H, Pardo-Saganta A et al (2013) Dedifferentiation of committed epithelial cells into stem cells in vivo. Nature 503:218–223PubMedCentralPubMed
18.
Zurück zum Zitat Nutt SL, Heavey B, Rolink AG, Busslinger M (1999) Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 401:556–562PubMedCrossRef Nutt SL, Heavey B, Rolink AG, Busslinger M (1999) Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 401:556–562PubMedCrossRef
19.
Zurück zum Zitat Gurdon JB, Elsdale TR, Fischberg M (1958) Sexually mature individuals of Xenopus laevis from the transplantation of single somatic nuclei. Nature 182:64–65PubMedCrossRef Gurdon JB, Elsdale TR, Fischberg M (1958) Sexually mature individuals of Xenopus laevis from the transplantation of single somatic nuclei. Nature 182:64–65PubMedCrossRef
20.
Zurück zum Zitat Olbrot M, Rud J, Moss LG, Sharma A (2002) Identification of beta-cell-specific insulin gene transcription factor RIPE3b1 as mammalian MafA. Proc Natl Acad Sci U S A 99:6737–6742PubMedCentralPubMedCrossRef Olbrot M, Rud J, Moss LG, Sharma A (2002) Identification of beta-cell-specific insulin gene transcription factor RIPE3b1 as mammalian MafA. Proc Natl Acad Sci U S A 99:6737–6742PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat Nishimura W, Kondo T, Salameh T et al (2006) A switch from MafB to MafA expression accompanies differentiation to pancreatic beta-cells. Dev Biol 293:526–539PubMedCentralPubMedCrossRef Nishimura W, Kondo T, Salameh T et al (2006) A switch from MafB to MafA expression accompanies differentiation to pancreatic beta-cells. Dev Biol 293:526–539PubMedCentralPubMedCrossRef
22.
23.
Zurück zum Zitat Nishimura W, Bonner-Weir S, Sharma A (2009) Expression of MafA in pancreatic progenitors is detrimental for pancreatic development. Dev Biol 333:108–120PubMedCentralPubMedCrossRef Nishimura W, Bonner-Weir S, Sharma A (2009) Expression of MafA in pancreatic progenitors is detrimental for pancreatic development. Dev Biol 333:108–120PubMedCentralPubMedCrossRef
24.
Zurück zum Zitat Kaneto H, Matsuoka TA, Nakatani Y et al (2005) A crucial role of MafA as a novel therapeutic target for diabetes. J Biol Chem 280:15047–15052PubMedCrossRef Kaneto H, Matsuoka TA, Nakatani Y et al (2005) A crucial role of MafA as a novel therapeutic target for diabetes. J Biol Chem 280:15047–15052PubMedCrossRef
25.
Zurück zum Zitat Butler AE, Robertson RP, Hernandez R, Matveyenko AV, Gurlo T, Butler PC (2012) Beta cell nuclear musculoaponeurotic fibrosarcoma oncogene family A (MafA) is deficient in type 2 diabetes. Diabetologia 55:2985–2988PubMedCentralPubMedCrossRef Butler AE, Robertson RP, Hernandez R, Matveyenko AV, Gurlo T, Butler PC (2012) Beta cell nuclear musculoaponeurotic fibrosarcoma oncogene family A (MafA) is deficient in type 2 diabetes. Diabetologia 55:2985–2988PubMedCentralPubMedCrossRef
26.
27.
28.
Zurück zum Zitat Moriguchi T, Hamada M, Morito N et al (2006) MafB is essential for renal development and F4/80 expression in macrophages. Mol Cell Biol 26:5715–5727PubMedCentralPubMedCrossRef Moriguchi T, Hamada M, Morito N et al (2006) MafB is essential for renal development and F4/80 expression in macrophages. Mol Cell Biol 26:5715–5727PubMedCentralPubMedCrossRef
29.
Zurück zum Zitat Nishimura W, Eto K, Miki A et al (2013) Quantitative assessment of Pdx1 promoter activity in vivo using a secreted luciferase reporter system. Endocrinology 154:4388–4395PubMedCrossRef Nishimura W, Eto K, Miki A et al (2013) Quantitative assessment of Pdx1 promoter activity in vivo using a secreted luciferase reporter system. Endocrinology 154:4388–4395PubMedCrossRef
30.
Zurück zum Zitat Shirato Y, Tamura M, Yoneda M, Nemoto S (2006) Centrosome destined to decay in starfish oocytes. Development 133:343–350PubMedCrossRef Shirato Y, Tamura M, Yoneda M, Nemoto S (2006) Centrosome destined to decay in starfish oocytes. Development 133:343–350PubMedCrossRef
31.
Zurück zum Zitat Hang Y, Yamamoto T, Benninger RK et al (2014) The MafA transcription factor becomes essential to islet β-cells soon after birth. Diabetes 63:1994–2005PubMedCrossRef Hang Y, Yamamoto T, Benninger RK et al (2014) The MafA transcription factor becomes essential to islet β-cells soon after birth. Diabetes 63:1994–2005PubMedCrossRef
33.
Zurück zum Zitat Laybutt DR, Hawkins YC, Lock J et al (2007) Influence of diabetes on the loss of beta cell differentiation after islet transplantation in rats. Diabetologia 50:2117–2125PubMedCrossRef Laybutt DR, Hawkins YC, Lock J et al (2007) Influence of diabetes on the loss of beta cell differentiation after islet transplantation in rats. Diabetologia 50:2117–2125PubMedCrossRef
34.
Zurück zum Zitat Pullen TJ, Rutter GA (2013) When less is more: the forbidden fruits of gene repression in the adult β-cell. Diabetes Obes Metab 15:503–512PubMedCrossRef Pullen TJ, Rutter GA (2013) When less is more: the forbidden fruits of gene repression in the adult β-cell. Diabetes Obes Metab 15:503–512PubMedCrossRef
35.
Zurück zum Zitat Thorrez L, Laudadio I, van Deun K et al (2011) Tissue-specific disallowance of housekeeping genes: the other face of cell differentiation. Genome Res 21:95–105PubMedCentralPubMedCrossRef Thorrez L, Laudadio I, van Deun K et al (2011) Tissue-specific disallowance of housekeeping genes: the other face of cell differentiation. Genome Res 21:95–105PubMedCentralPubMedCrossRef
36.
Zurück zum Zitat Neri F, Krepelova A, Incarnato D et al (2013) Dnmt3L antagonizes DNA methylation at bivalent promoters and favors DNA methylation at gene bodies in ESCs. Cell 26:121–134CrossRef Neri F, Krepelova A, Incarnato D et al (2013) Dnmt3L antagonizes DNA methylation at bivalent promoters and favors DNA methylation at gene bodies in ESCs. Cell 26:121–134CrossRef
37.
Zurück zum Zitat Harmon JS, Stein R, Robertson RP (2005) Oxidative stress-mediated, post-translational loss of MafA protein as a contributing mechanism to loss of insulin gene expression in glucotoxic beta cells. J Biol Chem 280:11107–11113PubMedCrossRef Harmon JS, Stein R, Robertson RP (2005) Oxidative stress-mediated, post-translational loss of MafA protein as a contributing mechanism to loss of insulin gene expression in glucotoxic beta cells. J Biol Chem 280:11107–11113PubMedCrossRef
38.
Zurück zum Zitat Matsuoka TA, Kaneto H, Miyatsuka T et al (2010) Regulation of MafA expression in pancreatic beta-cells in db/db mice with diabetes. Diabetes 59:1709–1720PubMedCentralPubMedCrossRef Matsuoka TA, Kaneto H, Miyatsuka T et al (2010) Regulation of MafA expression in pancreatic beta-cells in db/db mice with diabetes. Diabetes 59:1709–1720PubMedCentralPubMedCrossRef
39.
Zurück zum Zitat Vicente-Dueñas C, Romero-Camarero I, González-Herrero I et al (2012) A novel molecular mechanism involved in multiple myeloma development revealed by targeting MafB to haematopoietic progenitors. EMBO J 31:3704–3717PubMedCentralPubMedCrossRef Vicente-Dueñas C, Romero-Camarero I, González-Herrero I et al (2012) A novel molecular mechanism involved in multiple myeloma development revealed by targeting MafB to haematopoietic progenitors. EMBO J 31:3704–3717PubMedCentralPubMedCrossRef
40.
Zurück zum Zitat Bramswig NC, Everett LJ, Schug J et al (2013) Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming. J Clin Invest 123:1275–1284PubMedCentralPubMedCrossRef Bramswig NC, Everett LJ, Schug J et al (2013) Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming. J Clin Invest 123:1275–1284PubMedCentralPubMedCrossRef
Metadaten
Titel
MafA is critical for maintenance of the mature beta cell phenotype in mice
verfasst von
Wataru Nishimura
Satoru Takahashi
Kazuki Yasuda
Publikationsdatum
01.03.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Diabetologia / Ausgabe 3/2015
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-014-3464-9

Weitere Artikel der Ausgabe 3/2015

Diabetologia 3/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.